12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smarcc1
|
ENSMUSG00000032481.10 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
Fosl1
|
ENSMUSG00000024912.5 | fos-like antigen 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Smarcc1 | mm10_v2_chr9_+_110132015_110132102 | -0.92 | 6.5e-05 | Click! |
Fosl1 | mm10_v2_chr19_+_5447692_5447711 | -0.74 | 8.8e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_25754327 | 3.56 |
ENSMUST00000075884.6
|
Msln
|
mesothelin |
chr11_+_120530688 | 3.16 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr2_-_62483637 | 3.00 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chr4_-_106804998 | 2.67 |
ENSMUST00000065253.6
|
Acot11
|
acyl-CoA thioesterase 11 |
chr7_+_141079759 | 2.55 |
ENSMUST00000066873.4
ENSMUST00000163041.1 |
Pkp3
|
plakophilin 3 |
chr1_-_134235420 | 2.47 |
ENSMUST00000038191.6
ENSMUST00000086465.4 |
Adora1
|
adenosine A1 receptor |
chr11_+_61684419 | 2.41 |
ENSMUST00000093019.5
|
Fam83g
|
family with sequence similarity 83, member G |
chr10_-_44004846 | 2.34 |
ENSMUST00000020017.8
|
Aim1
|
absent in melanoma 1 |
chr4_-_127358124 | 2.28 |
ENSMUST00000046498.2
|
Gjb5
|
gap junction protein, beta 5 |
chrX_+_52791179 | 2.21 |
ENSMUST00000101588.1
|
Ccdc160
|
coiled-coil domain containing 160 |
chr11_+_61065798 | 2.20 |
ENSMUST00000041944.2
ENSMUST00000108717.2 |
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr13_+_119623819 | 1.83 |
ENSMUST00000099241.2
|
Ccl28
|
chemokine (C-C motif) ligand 28 |
chr14_+_65968483 | 1.77 |
ENSMUST00000022616.6
|
Clu
|
clusterin |
chr3_+_122729158 | 1.76 |
ENSMUST00000066728.5
|
Pde5a
|
phosphodiesterase 5A, cGMP-specific |
chr5_-_93045022 | 1.73 |
ENSMUST00000061328.5
|
Sowahb
|
sosondowah ankyrin repeat domain family member B |
chr5_-_86906937 | 1.70 |
ENSMUST00000031181.9
ENSMUST00000113333.1 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr9_-_96862903 | 1.69 |
ENSMUST00000121077.1
ENSMUST00000124923.1 |
Acpl2
|
acid phosphatase-like 2 |
chr3_+_60081861 | 1.67 |
ENSMUST00000029326.5
|
Sucnr1
|
succinate receptor 1 |
chr6_-_112489808 | 1.63 |
ENSMUST00000053306.6
|
Oxtr
|
oxytocin receptor |
chr10_-_127041513 | 1.60 |
ENSMUST00000116231.2
|
Mettl21b
|
methyltransferase like 21B |
chr7_-_44816586 | 1.58 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr10_+_128267997 | 1.56 |
ENSMUST00000050901.2
|
Apof
|
apolipoprotein F |
chr14_+_41105359 | 1.53 |
ENSMUST00000047286.6
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr17_+_55952623 | 1.52 |
ENSMUST00000003274.6
|
Ebi3
|
Epstein-Barr virus induced gene 3 |
chr10_+_69212634 | 1.51 |
ENSMUST00000020101.5
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr9_+_46998931 | 1.50 |
ENSMUST00000178065.1
|
Gm4791
|
predicted gene 4791 |
chr7_+_19083842 | 1.47 |
ENSMUST00000032568.7
ENSMUST00000122999.1 ENSMUST00000108473.3 ENSMUST00000108474.1 |
Dmpk
|
dystrophia myotonica-protein kinase |
chr9_+_103112072 | 1.46 |
ENSMUST00000035155.6
|
Rab6b
|
RAB6B, member RAS oncogene family |
chr11_-_58534825 | 1.42 |
ENSMUST00000170009.1
|
Olfr330
|
olfactory receptor 330 |
chr4_-_131672133 | 1.42 |
ENSMUST00000144212.1
|
Gm12962
|
predicted gene 12962 |
chr11_-_109298121 | 1.41 |
ENSMUST00000020920.3
|
Rgs9
|
regulator of G-protein signaling 9 |
chr6_-_124769548 | 1.40 |
ENSMUST00000149652.1
ENSMUST00000112476.1 ENSMUST00000004378.8 |
Eno2
|
enolase 2, gamma neuronal |
chr2_+_164948219 | 1.40 |
ENSMUST00000017881.2
|
Mmp9
|
matrix metallopeptidase 9 |
chr7_+_79810727 | 1.39 |
ENSMUST00000107394.1
|
Mesp2
|
mesoderm posterior 2 |
chr9_-_20728219 | 1.38 |
ENSMUST00000034692.7
|
Olfm2
|
olfactomedin 2 |
chr1_-_171437288 | 1.36 |
ENSMUST00000181499.1
|
Gm26641
|
predicted gene, 26641 |
chr17_-_28915314 | 1.36 |
ENSMUST00000062357.4
|
4930539E08Rik
|
RIKEN cDNA 4930539E08 gene |
chr18_-_82406777 | 1.35 |
ENSMUST00000065224.6
|
Galr1
|
galanin receptor 1 |
chr4_-_140648736 | 1.34 |
ENSMUST00000039204.3
ENSMUST00000105799.1 ENSMUST00000097820.2 |
Arhgef10l
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr4_+_150927918 | 1.33 |
ENSMUST00000139826.1
ENSMUST00000116257.1 |
Tnfrsf9
|
tumor necrosis factor receptor superfamily, member 9 |
chr7_-_101864093 | 1.32 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr6_-_5256226 | 1.32 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr1_+_125561010 | 1.28 |
ENSMUST00000027580.4
|
Slc35f5
|
solute carrier family 35, member F5 |
chr6_+_139736895 | 1.27 |
ENSMUST00000111868.3
|
Pik3c2g
|
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide |
chr12_-_24680890 | 1.27 |
ENSMUST00000156453.2
|
Cys1
|
cystin 1 |
chr16_+_17561885 | 1.25 |
ENSMUST00000171002.1
ENSMUST00000023441.4 |
P2rx6
|
purinergic receptor P2X, ligand-gated ion channel, 6 |
chr2_-_35100677 | 1.24 |
ENSMUST00000045776.4
ENSMUST00000113050.3 |
AI182371
|
expressed sequence AI182371 |
chr17_+_87635974 | 1.23 |
ENSMUST00000053577.8
|
Epcam
|
epithelial cell adhesion molecule |
chr1_+_134182150 | 1.22 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr1_+_125676969 | 1.21 |
ENSMUST00000027581.6
|
Gpr39
|
G protein-coupled receptor 39 |
chr18_-_80247102 | 1.20 |
ENSMUST00000166219.1
|
Hsbp1l1
|
heat shock factor binding protein 1-like 1 |
chr7_+_141079125 | 1.20 |
ENSMUST00000159375.1
|
Pkp3
|
plakophilin 3 |
chr4_-_140665891 | 1.20 |
ENSMUST00000069623.5
|
Arhgef10l
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr7_+_44816364 | 1.20 |
ENSMUST00000118125.1
|
Il4i1
|
interleukin 4 induced 1 |
chr2_-_25461021 | 1.19 |
ENSMUST00000151239.1
|
BC029214
|
cDNA sequence BC029214 |
chr7_+_80246375 | 1.18 |
ENSMUST00000058266.6
|
Ttll13
|
tubulin tyrosine ligase-like family, member 13 |
chr5_-_139814231 | 1.16 |
ENSMUST00000044002.4
|
Tmem184a
|
transmembrane protein 184a |
chrX_+_164162167 | 1.13 |
ENSMUST00000131543.1
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr14_+_41131777 | 1.13 |
ENSMUST00000022314.3
ENSMUST00000170719.1 |
Sftpa1
|
surfactant associated protein A1 |
chr14_-_13914478 | 1.11 |
ENSMUST00000144914.1
|
Gm281
|
predicted gene 281 |
chr3_+_105870898 | 1.11 |
ENSMUST00000010279.5
|
Adora3
|
adenosine A3 receptor |
chr12_-_86988676 | 1.10 |
ENSMUST00000095521.2
|
Zdhhc22
|
zinc finger, DHHC-type containing 22 |
chr7_+_28863831 | 1.10 |
ENSMUST00000138272.1
|
Lgals7
|
lectin, galactose binding, soluble 7 |
chr1_-_162866502 | 1.09 |
ENSMUST00000046049.7
|
Fmo1
|
flavin containing monooxygenase 1 |
chr12_+_11456052 | 1.08 |
ENSMUST00000124065.1
|
Rad51ap2
|
RAD51 associated protein 2 |
chr16_-_32797413 | 1.08 |
ENSMUST00000115116.1
ENSMUST00000041123.8 |
Muc20
|
mucin 20 |
chr11_+_96931387 | 1.08 |
ENSMUST00000107633.1
|
Prr15l
|
proline rich 15-like |
chr3_-_107986408 | 1.08 |
ENSMUST00000012348.2
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr1_-_182517447 | 1.07 |
ENSMUST00000068505.8
|
Capn2
|
calpain 2 |
chr19_-_36736653 | 1.06 |
ENSMUST00000087321.2
|
Ppp1r3c
|
protein phosphatase 1, regulatory (inhibitor) subunit 3C |
chr8_+_11477921 | 1.06 |
ENSMUST00000180408.1
|
E230013L22Rik
|
RIKEN cDNA E230013L22 gene |
chr6_+_49036518 | 1.03 |
ENSMUST00000031840.7
|
Gpnmb
|
glycoprotein (transmembrane) nmb |
chr3_-_92485886 | 1.03 |
ENSMUST00000054599.7
|
Sprr1a
|
small proline-rich protein 1A |
chr16_+_30008657 | 1.01 |
ENSMUST00000181485.1
|
4632428C04Rik
|
RIKEN cDNA 4632428C04 gene |
chr11_-_31824518 | 1.01 |
ENSMUST00000134944.1
|
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr6_-_37442095 | 1.00 |
ENSMUST00000041093.5
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr16_+_17331371 | 1.00 |
ENSMUST00000023450.6
ENSMUST00000161034.1 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr2_+_181219998 | 0.99 |
ENSMUST00000050026.6
ENSMUST00000108835.1 |
BC051628
|
cDNA sequence BC051628 |
chr8_+_70724064 | 0.99 |
ENSMUST00000034307.7
ENSMUST00000110095.2 |
Pde4c
|
phosphodiesterase 4C, cAMP specific |
chr11_-_100207507 | 0.98 |
ENSMUST00000007272.7
|
Krt14
|
keratin 14 |
chr16_-_17838173 | 0.98 |
ENSMUST00000118960.1
|
Car15
|
carbonic anhydrase 15 |
chr6_+_39381175 | 0.98 |
ENSMUST00000031986.4
|
Rab19
|
RAB19, member RAS oncogene family |
chr10_+_60277627 | 0.97 |
ENSMUST00000105465.1
ENSMUST00000177779.1 ENSMUST00000179238.1 ENSMUST00000004316.8 |
Psap
|
prosaposin |
chr16_-_22439719 | 0.97 |
ENSMUST00000079601.6
|
Etv5
|
ets variant gene 5 |
chr2_+_152105722 | 0.97 |
ENSMUST00000099225.2
|
Srxn1
|
sulfiredoxin 1 homolog (S. cerevisiae) |
chr11_+_106374820 | 0.96 |
ENSMUST00000106816.1
|
2310007L24Rik
|
RIKEN cDNA 2310007L24 gene |
chr7_-_3677509 | 0.96 |
ENSMUST00000038743.8
|
Tmc4
|
transmembrane channel-like gene family 4 |
chr7_+_141468776 | 0.96 |
ENSMUST00000058746.5
|
Cd151
|
CD151 antigen |
chr10_+_81633694 | 0.95 |
ENSMUST00000140345.1
ENSMUST00000126323.1 |
Ankrd24
|
ankyrin repeat domain 24 |
chr11_+_87760533 | 0.95 |
ENSMUST00000039627.5
ENSMUST00000100644.3 |
Bzrap1
|
benzodiazepine receptor associated protein 1 |
chr14_+_103513328 | 0.94 |
ENSMUST00000095576.3
|
Scel
|
sciellin |
chr1_-_84284548 | 0.93 |
ENSMUST00000177458.1
ENSMUST00000168574.2 |
Pid1
|
phosphotyrosine interaction domain containing 1 |
chr12_+_59095653 | 0.93 |
ENSMUST00000021384.4
|
Mia2
|
melanoma inhibitory activity 2 |
chr10_-_64090265 | 0.93 |
ENSMUST00000105439.1
|
Lrrtm3
|
leucine rich repeat transmembrane neuronal 3 |
chr1_+_55052770 | 0.92 |
ENSMUST00000027125.5
ENSMUST00000087617.4 |
Coq10b
|
coenzyme Q10 homolog B (S. cerevisiae) |
chr9_+_7347374 | 0.92 |
ENSMUST00000065079.5
ENSMUST00000005950.5 |
Mmp12
|
matrix metallopeptidase 12 |
chr6_+_87778084 | 0.91 |
ENSMUST00000032133.3
|
Gp9
|
glycoprotein 9 (platelet) |
chr4_+_118527229 | 0.91 |
ENSMUST00000030261.5
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr1_-_153186447 | 0.91 |
ENSMUST00000027753.6
|
Lamc2
|
laminin, gamma 2 |
chr7_+_140835018 | 0.90 |
ENSMUST00000106050.1
ENSMUST00000026554.4 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr2_+_174760619 | 0.90 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr13_-_54611274 | 0.90 |
ENSMUST00000049575.7
|
Cltb
|
clathrin, light polypeptide (Lcb) |
chr13_+_95696851 | 0.90 |
ENSMUST00000022182.4
|
F2rl2
|
coagulation factor II (thrombin) receptor-like 2 |
chr1_+_157526127 | 0.90 |
ENSMUST00000111700.1
|
Sec16b
|
SEC16 homolog B (S. cerevisiae) |
chr4_-_127354074 | 0.89 |
ENSMUST00000106090.1
ENSMUST00000060419.1 |
Gjb4
|
gap junction protein, beta 4 |
chr11_+_69964758 | 0.89 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr7_+_24777172 | 0.88 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr17_+_32536555 | 0.88 |
ENSMUST00000169591.1
ENSMUST00000003416.8 |
Cyp4f16
|
cytochrome P450, family 4, subfamily f, polypeptide 16 |
chr2_+_160880642 | 0.88 |
ENSMUST00000109456.2
|
Lpin3
|
lipin 3 |
chr16_+_32735886 | 0.88 |
ENSMUST00000132475.1
ENSMUST00000096106.3 |
Muc4
|
mucin 4 |
chr16_+_33062512 | 0.87 |
ENSMUST00000023497.2
|
Lmln
|
leishmanolysin-like (metallopeptidase M8 family) |
chr4_-_19922599 | 0.87 |
ENSMUST00000029900.5
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr1_-_136230289 | 0.87 |
ENSMUST00000150163.1
ENSMUST00000144464.1 |
5730559C18Rik
|
RIKEN cDNA 5730559C18 gene |
chr3_-_96263311 | 0.87 |
ENSMUST00000171473.1
|
Hist2h4
|
histone cluster 2, H4 |
chr11_+_9118070 | 0.86 |
ENSMUST00000020677.1
ENSMUST00000101525.2 ENSMUST00000170444.1 |
Upp1
|
uridine phosphorylase 1 |
chr18_-_61536522 | 0.86 |
ENSMUST00000171629.1
|
Arhgef37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
chr7_+_105554360 | 0.86 |
ENSMUST00000046983.8
|
Smpd1
|
sphingomyelin phosphodiesterase 1, acid lysosomal |
chr1_+_58029931 | 0.86 |
ENSMUST00000001027.6
|
Aox1
|
aldehyde oxidase 1 |
chr7_-_104353328 | 0.86 |
ENSMUST00000130139.1
ENSMUST00000059037.8 |
Trim12c
|
tripartite motif-containing 12C |
chr7_+_78913765 | 0.86 |
ENSMUST00000038142.8
|
Isg20
|
interferon-stimulated protein |
chr10_+_69212676 | 0.85 |
ENSMUST00000167384.1
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr17_-_57000018 | 0.85 |
ENSMUST00000002740.2
|
Pspn
|
persephin |
chr1_-_156034800 | 0.85 |
ENSMUST00000169241.1
|
Tor1aip1
|
torsin A interacting protein 1 |
chr15_-_98728120 | 0.85 |
ENSMUST00000003445.6
|
Fkbp11
|
FK506 binding protein 11 |
chr12_-_79007276 | 0.84 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr1_+_59256906 | 0.84 |
ENSMUST00000160662.1
ENSMUST00000114248.2 |
Cdk15
|
cyclin-dependent kinase 15 |
chr2_+_24336846 | 0.84 |
ENSMUST00000114487.2
|
Il1rn
|
interleukin 1 receptor antagonist |
chr4_+_138967112 | 0.84 |
ENSMUST00000116094.2
|
Rnf186
|
ring finger protein 186 |
chr2_-_25461094 | 0.84 |
ENSMUST00000114261.2
|
BC029214
|
cDNA sequence BC029214 |
chr9_+_108953578 | 0.83 |
ENSMUST00000112070.1
|
Col7a1
|
collagen, type VII, alpha 1 |
chr3_+_96670131 | 0.83 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr15_+_80255184 | 0.83 |
ENSMUST00000109605.3
|
Atf4
|
activating transcription factor 4 |
chr7_-_100656953 | 0.83 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr7_+_27486910 | 0.82 |
ENSMUST00000008528.7
|
Sertad1
|
SERTA domain containing 1 |
chr3_-_107986360 | 0.82 |
ENSMUST00000066530.6
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr4_+_43267165 | 0.81 |
ENSMUST00000107942.2
ENSMUST00000102953.3 |
Atp8b5
|
ATPase, class I, type 8B, member 5 |
chr15_+_9436028 | 0.81 |
ENSMUST00000042360.3
|
Capsl
|
calcyphosine-like |
chr11_+_58379036 | 0.81 |
ENSMUST00000013787.4
ENSMUST00000108826.2 |
Lypd8
|
LY6/PLAUR domain containing 8 |
chr6_+_78425973 | 0.81 |
ENSMUST00000079926.5
|
Reg1
|
regenerating islet-derived 1 |
chr2_+_105126505 | 0.80 |
ENSMUST00000143043.1
|
Wt1
|
Wilms tumor 1 homolog |
chr3_+_103576081 | 0.80 |
ENSMUST00000183637.1
ENSMUST00000117221.2 ENSMUST00000118117.1 ENSMUST00000118563.2 |
Syt6
|
synaptotagmin VI |
chr10_-_83534130 | 0.80 |
ENSMUST00000020497.7
|
Aldh1l2
|
aldehyde dehydrogenase 1 family, member L2 |
chr5_+_30466044 | 0.79 |
ENSMUST00000031078.3
ENSMUST00000114743.1 |
1700001C02Rik
|
RIKEN cDNA 1700001C02 gene |
chr10_+_127290774 | 0.79 |
ENSMUST00000026475.8
ENSMUST00000139091.1 |
Ddit3
|
DNA-damage inducible transcript 3 |
chr2_-_25196759 | 0.79 |
ENSMUST00000081869.6
|
Tor4a
|
torsin family 4, member A |
chr19_+_42052228 | 0.79 |
ENSMUST00000164518.2
|
4933411K16Rik
|
RIKEN cDNA 4933411K16 gene |
chr1_+_33908172 | 0.78 |
ENSMUST00000182513.1
ENSMUST00000183034.1 |
Dst
|
dystonin |
chr1_-_121327734 | 0.78 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr11_+_120467635 | 0.78 |
ENSMUST00000140862.1
ENSMUST00000106205.1 ENSMUST00000106203.1 ENSMUST00000026900.7 |
Hgs
|
HGF-regulated tyrosine kinase substrate |
chr8_+_94172618 | 0.77 |
ENSMUST00000034214.6
|
Mt2
|
metallothionein 2 |
chr7_-_109616548 | 0.77 |
ENSMUST00000077909.1
ENSMUST00000084738.3 |
St5
|
suppression of tumorigenicity 5 |
chr8_+_105305572 | 0.77 |
ENSMUST00000109375.2
|
Elmo3
|
engulfment and cell motility 3 |
chr6_-_85832082 | 0.76 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr15_-_54278420 | 0.76 |
ENSMUST00000079772.3
|
Tnfrsf11b
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
chr13_-_54611332 | 0.76 |
ENSMUST00000091609.4
|
Cltb
|
clathrin, light polypeptide (Lcb) |
chr4_-_148151646 | 0.75 |
ENSMUST00000132083.1
|
Fbxo6
|
F-box protein 6 |
chr4_-_148151878 | 0.75 |
ENSMUST00000105706.1
ENSMUST00000030858.7 ENSMUST00000134261.1 |
Fbxo6
|
F-box protein 6 |
chr9_+_45042425 | 0.75 |
ENSMUST00000034600.4
|
Mpzl2
|
myelin protein zero-like 2 |
chr17_+_57062231 | 0.75 |
ENSMUST00000097299.3
ENSMUST00000169543.1 ENSMUST00000163763.1 |
Crb3
|
crumbs homolog 3 (Drosophila) |
chr5_-_138996087 | 0.75 |
ENSMUST00000110897.1
|
Pdgfa
|
platelet derived growth factor, alpha |
chr11_-_109298066 | 0.75 |
ENSMUST00000106706.1
|
Rgs9
|
regulator of G-protein signaling 9 |
chr17_+_34931253 | 0.75 |
ENSMUST00000007253.5
|
Neu1
|
neuraminidase 1 |
chr7_+_18839954 | 0.75 |
ENSMUST00000072386.4
ENSMUST00000072415.6 |
Mill2
|
MHC I like leukocyte 2 |
chr1_-_13127163 | 0.75 |
ENSMUST00000047577.6
|
Prdm14
|
PR domain containing 14 |
chr9_-_105828085 | 0.75 |
ENSMUST00000166431.2
ENSMUST00000098441.3 |
Col6a6
|
collagen, type VI, alpha 6 |
chr3_+_100825452 | 0.74 |
ENSMUST00000054791.7
|
Vtcn1
|
V-set domain containing T cell activation inhibitor 1 |
chr18_+_80255227 | 0.74 |
ENSMUST00000123750.1
|
Pqlc1
|
PQ loop repeat containing 1 |
chr9_+_108953597 | 0.73 |
ENSMUST00000026740.5
|
Col7a1
|
collagen, type VII, alpha 1 |
chrX_-_74023908 | 0.73 |
ENSMUST00000033769.8
ENSMUST00000114352.1 ENSMUST00000068286.5 ENSMUST00000114360.3 ENSMUST00000114354.3 |
Irak1
|
interleukin-1 receptor-associated kinase 1 |
chr13_-_65205716 | 0.73 |
ENSMUST00000037372.7
|
Nlrp4f
|
NLR family, pyrin domain containing 4F |
chr3_-_117868821 | 0.73 |
ENSMUST00000167877.1
ENSMUST00000169812.1 |
Snx7
|
sorting nexin 7 |
chr19_-_4139605 | 0.73 |
ENSMUST00000025761.6
|
Cabp4
|
calcium binding protein 4 |
chr19_-_6840590 | 0.72 |
ENSMUST00000170516.2
ENSMUST00000025903.5 |
Rps6ka4
|
ribosomal protein S6 kinase, polypeptide 4 |
chr9_+_98490522 | 0.72 |
ENSMUST00000035029.2
|
Rbp2
|
retinol binding protein 2, cellular |
chr7_+_30763750 | 0.72 |
ENSMUST00000165887.1
ENSMUST00000085691.4 ENSMUST00000085688.4 ENSMUST00000054427.6 |
Dmkn
|
dermokine |
chr12_-_103631404 | 0.72 |
ENSMUST00000121625.1
ENSMUST00000044231.5 |
Serpina10
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr16_-_75766758 | 0.72 |
ENSMUST00000114244.1
ENSMUST00000046283.8 |
Hspa13
|
heat shock protein 70 family, member 13 |
chr15_+_54571358 | 0.72 |
ENSMUST00000025356.2
|
Mal2
|
mal, T cell differentiation protein 2 |
chr2_+_157914618 | 0.72 |
ENSMUST00000109523.1
|
Vstm2l
|
V-set and transmembrane domain containing 2-like |
chr1_+_182564994 | 0.72 |
ENSMUST00000048941.7
ENSMUST00000168514.1 |
Capn8
|
calpain 8 |
chr5_+_102845007 | 0.71 |
ENSMUST00000070000.4
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr4_-_40722307 | 0.71 |
ENSMUST00000181475.1
|
Gm6297
|
predicted gene 6297 |
chr1_+_75236439 | 0.71 |
ENSMUST00000082158.6
ENSMUST00000055223.7 |
Dnajb2
|
DnaJ (Hsp40) homolog, subfamily B, member 2 |
chr7_+_78914216 | 0.71 |
ENSMUST00000120331.2
|
Isg20
|
interferon-stimulated protein |
chr14_+_59625281 | 0.71 |
ENSMUST00000053949.5
|
Shisa2
|
shisa homolog 2 (Xenopus laevis) |
chr7_+_139834148 | 0.71 |
ENSMUST00000026548.7
|
Gpr123
|
G protein-coupled receptor 123 |
chr14_+_65971049 | 0.71 |
ENSMUST00000128539.1
|
Clu
|
clusterin |
chr4_-_111902754 | 0.70 |
ENSMUST00000102719.1
ENSMUST00000102721.1 |
Slc5a9
|
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
chr4_+_100095791 | 0.70 |
ENSMUST00000039630.5
|
Ror1
|
receptor tyrosine kinase-like orphan receptor 1 |
chr17_+_35220834 | 0.70 |
ENSMUST00000118793.1
|
Gm16181
|
predicted gene 16181 |
chr3_+_105904377 | 0.70 |
ENSMUST00000000574.1
|
Adora3
|
adenosine A3 receptor |
chr17_+_34203527 | 0.70 |
ENSMUST00000025197.5
|
Tap2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
chr15_+_10314102 | 0.70 |
ENSMUST00000127467.1
|
Prlr
|
prolactin receptor |
chr4_+_118526986 | 0.69 |
ENSMUST00000106367.1
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chrX_-_101059655 | 0.69 |
ENSMUST00000113718.1
ENSMUST00000113716.2 |
Tex11
|
testis expressed gene 11 |
chr14_-_41185188 | 0.69 |
ENSMUST00000077136.3
|
Sftpd
|
surfactant associated protein D |
chr6_+_17463927 | 0.69 |
ENSMUST00000115442.1
|
Met
|
met proto-oncogene |
chr3_-_144819494 | 0.69 |
ENSMUST00000029929.7
|
Clca2
|
chloride channel calcium activated 2 |
chr11_-_69880971 | 0.68 |
ENSMUST00000050555.3
|
Kctd11
|
potassium channel tetramerisation domain containing 11 |
chrX_-_103186618 | 0.68 |
ENSMUST00000121720.1
|
Nap1l2
|
nucleosome assembly protein 1-like 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0042323 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.7 | 4.1 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 3.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 3.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 2.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 3.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.5 | 1.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 1.3 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.4 | 1.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 1.3 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.4 | 1.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 2.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 1.2 | GO:0035482 | gastric motility(GO:0035482) |
0.4 | 1.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.1 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.4 | 1.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.3 | 1.0 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.3 | 1.3 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.3 | 1.3 | GO:0006311 | meiotic gene conversion(GO:0006311) male meiosis chromosome segregation(GO:0007060) gene conversion(GO:0035822) |
0.3 | 1.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 0.9 | GO:0046968 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) peptide antigen transport(GO:0046968) |
0.3 | 1.2 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.3 | 2.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.3 | 0.8 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.3 | 0.8 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.3 | 1.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 1.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.3 | 0.8 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.3 | 0.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.3 | 0.8 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.3 | 0.8 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.3 | 1.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 | 2.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.8 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.2 | 0.5 | GO:0051794 | regulation of catagen(GO:0051794) |
0.2 | 1.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 1.5 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 0.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 0.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 0.4 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 1.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.2 | 1.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 0.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.2 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 0.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 2.0 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.2 | 1.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.8 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 1.0 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.2 | 1.3 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.2 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.2 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.6 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 1.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.9 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 0.9 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 0.5 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 0.7 | GO:1990743 | protein sialylation(GO:1990743) |
0.2 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 0.5 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.2 | 3.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 2.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.5 | GO:0090264 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.2 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 0.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.9 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 1.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.6 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.1 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.3 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.4 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 1.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 1.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 1.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.5 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.4 | GO:1900019 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.5 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.9 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 0.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 1.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.4 | GO:1904046 | seryl-tRNA aminoacylation(GO:0006434) negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 1.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.0 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.3 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.3 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.3 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 1.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.7 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 1.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.3 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.1 | 1.0 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.4 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 1.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.2 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.4 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.4 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.2 | GO:1904849 | corticotropin hormone secreting cell differentiation(GO:0060128) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 1.0 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.2 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.5 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.6 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.1 | 0.2 | GO:0071846 | actin filament debranching(GO:0071846) |
0.1 | 0.6 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 1.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:0048295 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of isotype switching to IgE isotypes(GO:0048295) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.1 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.9 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 2.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.2 | GO:0007314 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.1 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.2 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.1 | 0.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.5 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.2 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.1 | 0.3 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.2 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.2 | GO:0032379 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.0 | 0.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 0.1 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.0 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 1.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.2 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.1 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.0 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 3.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.0 | 0.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.0 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.3 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.0 | 0.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.2 | GO:0046210 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.2 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.4 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.0 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.0 | 0.2 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.4 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.0 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.1 | GO:0032899 | regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
0.0 | 0.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 1.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.8 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.0 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 1.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.1 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.0 | 0.6 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
0.0 | 0.2 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 1.0 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 1.0 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.7 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.2 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 1.1 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 1.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.5 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.1 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.4 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.5 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.2 | GO:0042069 | regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.0 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.5 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.3 | GO:0071545 | inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0031649 | heat generation(GO:0031649) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.3 | GO:0070542 | response to fatty acid(GO:0070542) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 1.7 | GO:0050817 | blood coagulation(GO:0007596) coagulation(GO:0050817) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.0 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 4.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 2.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 0.8 | GO:0005713 | recombination nodule(GO:0005713) |
0.2 | 0.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.8 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 1.0 | GO:0071914 | prominosome(GO:0071914) |
0.2 | 0.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.2 | 2.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 0.7 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.2 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.5 | GO:0036019 | endolysosome(GO:0036019) |
0.2 | 3.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.2 | 0.8 | GO:0031673 | H zone(GO:0031673) |
0.2 | 1.1 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 1.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 2.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.9 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 2.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.1 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 1.1 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 2.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.2 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.0 | 0.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 3.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 2.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 1.7 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.5 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 1.7 | GO:0005118 | sevenless binding(GO:0005118) |
0.4 | 4.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.4 | 1.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 1.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.9 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.3 | 1.2 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.3 | 2.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.8 | GO:0045352 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.3 | 1.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.3 | 0.8 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.3 | 1.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 4.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 0.7 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 1.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.2 | 0.7 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 0.7 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.2 | 0.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 1.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.6 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.2 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 4.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.9 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.2 | 0.5 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 1.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 0.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 0.5 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.2 | 0.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 2.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 2.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 1.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.5 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.1 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 3.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 3.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.9 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.3 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.3 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 2.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 2.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 1.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.1 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.8 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.2 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.1 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.0 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.2 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 3.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 1.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0032029 | myosin tail binding(GO:0032029) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0052870 | alkane 1-monooxygenase activity(GO:0018685) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.0 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 2.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.4 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 1.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 2.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 1.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 2.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.8 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 4.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 1.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.8 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 3.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 1.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 4.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 4.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 3.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 2.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 3.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 4.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 3.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 2.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 1.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |